Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | UCHL3 | P15374 | 1/20 | 1.00 |
| ▸ | GALR3 | O60755 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.73 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.73 |
| ▸ | SLCO2A1 | Q92959 | 2/20 | 0.62 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.62 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.56 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.56 |
| ▸ | PTGER1 | P34995 | 3/20 | 0.56 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13649348 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL8350588 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL22607967 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL13905975 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL5700584 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL25608056 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL8350586 | 1.00 | MAPT (1.00) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL14948544 | 0.92 | MAPT (0.85) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL10865862 | 0.92 | MAPT (0.85) | MAPTUCHL3GALR3ALDH1A1TRPA1 | |
| SCHEMBL11119548 | 0.92 | MAPT (0.85) | MAPTUCHL3GALR3ALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2166 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099917-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, AND DEVICE FOR PRODUCING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| WO-2026099311-A2 | MICROBIAL CELL FACTORIES PRODUCING PROSTAGLANDINS | RIVER STONE BIOTECH APS (DK) | 2026-05-15 | — | — | WO | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260090969-A1 | COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS | Nuchido Limited (GB) | 2026-04-02 | — | — | US | claimed |
| EP-4713459-A2 | ANTI-VISTA ANTIBODY RNA OR NUCLEIC ACID CONJUGATES (ARCS OR ANCS), COMPOSITIONS CONTAINING, AND THERAPEUTIC USE THEREOF | LIFORDI IMMUNOTHERAPEUTICS, INC. (US) | 2026-03-25 | — | — | EP | claimed |
| EP-3452041-B1 | COMPOSITIONS AND METHODS FOR ADMINISTERING PPAR-GAMMA-AGONISTS, SURFACTANT PEPTIDES AND PHOSPHOLIPIDS | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) | 2026-01-14 | — | — | EP | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-12409182-B2 | Compositions and uses thereof for treatment of idiopathic preterm birth | UNIVERSITY OF SOUTH FLORIDA (US) | 2025-09-09 | — | — | US | claimed |
| US-20250216407-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. | 2025-07-03 | — | — | US | claimed |
| EP-3980465-A1 | ENGINEERED PH-DEPENDENT ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE | Adimab, LLC (US) | 2022-04-13 | — | — | EP | claimed |
| US-20220096494-A1 | PREVENTION OF PRETERM BIRTH (PTB) BY INHIBITION OF FKBP51 | UNIVERSITY OF SOUTH FLORIDA, | 2022-03-31 | — | — | US | claimed |
| EP-3973000-A1 | HIGH AFFINITY ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE | Adimab, LLC (US) | 2022-03-30 | — | — | EP | claimed |
| US-20220088032-A1 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF IDIOPATHIC PRETERM BIRTH | UNIVERSITY OF SOUTH FLORIDA | 2022-03-24 | — | — | US | claimed |
| CN-114174339-A | High affinity anti-CD 3 antibodies and methods of making and using the same | 阿迪马布有限责任公司 | 2022-03-11 | — | — | CN | claimed |
| CN-114144437-A | Engineered pH-dependent anti-CD 3 antibodies and methods of making and using the same | 阿迪马布有限责任公司 | 2022-03-04 | — | — | CN | claimed |
| CN-111658628-B | Application of GLI2 inhibitor and screening method of compound inhibiting GLI2 | 中国科学院动物研究所 | 2022-03-01 | — | — | CN | claimed |
| US-20220057384-A1 | SLEEP MODULATION AGENT | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-02-24 | — | — | US | claimed |
| WO-2022032230-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING NEURODEGENERATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2022-02-10 | — | — | WO | claimed |
| US-3954844-A | (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters | G. D. SEARLE & CO. (US) | 1976-05-04 | — | — | US | claimed |